|

Search

Patients
EXPLORE PATIENTS
Fight Cancer Smarter
Patient Services
Share Your Story
What is a Biomarker?
Talk to Your Physician
Find a Doctor
Patient Stories
Testing Consent
Financial Services
Pay Your Bill
Fight Cancer Smarter
What is a Biomarker?
Patient Services
Talk to Your Physician
Find a Doctor
Patient Stories
Testing Consent
Financial Services
Pay Your Bill
Share Your Story
Physicians
EXPLORE PHYSICIANS
Physician Tests
Physician Services
TISSUE
MI Cancer Seek
MI Clarity
MI Profile
MI Tumor Seek Hybrid
BLOOD
Caris Assure
Caris ChromoSeq
AI SIGNATURES
Caris GPSai
Caris FOLFIRSTai
Caris Molecular Tumor Board
Customer Support
Pathology Program
Right-In-Time Trials
Physician Tests
TISSUE
MI Cancer Seek
MI Clarity
MI Profile
MI Tumor Seek Hybrid
BLOOD
Caris Assure
Caris ChromoSeq
AI SIGNATURES
Caris GPSai
Caris FOLFIRSTai
Physician Services
Caris Molecular Tumor Board
Customer Support
Pathology Program
Right-In-Time Trials
Biopharma
EXPLORE BIOPHARMA
Core Services
Multimodal Data
Caris Discovery
Molecular Profiling
Clinical Trial Matching
Commercialization
Core Services
Molecular Profiling
Clinical Trial Matching
Commercialization
Multimodal Data
Caris Discovery
Research
EXPLORE RESEARCH
Publications
Artificial Intelligence
Product Pipeline
Manuscripts
Posters
Presentations
Abstracts
Caris CODEai
Nanoverse
Molecular Tumor Board Report
Publications
Manuscripts
Posters
Presentations
Abstracts
Artificial Intelligence
Caris CODEai
Nanoverse
Molecular Tumor Board Report
Product Pipeline
Partners
EXPLORE PARTNERS
Caris POA
EHR Integrations
International Distributors
Members
Working Groups
Fellows Forum
Caris POA
Members
Working Groups
Fellows Forum
EHR Integrations
International Distributors
News & Events
EXPLORE
News
Events
Media Library
Podcasts
Webinars
News
Events
Media Library
Podcasts
Webinars
LATEST NEWS

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

May 2026

Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies

May 2026
About
EXPLORE ABOUT
Careers
Leadership
Locations
Contact Us
Opportunities
Our People
Benefits
Careers
Opportunities
Our People
Benefits
Leadership
Locations
Contact Us

Home / Saudi Arabia

Caris News

Saudi Arabia

Contact Corporate Communications

Contact Caris Corporate Communications

Patients
Physicians
Biopharma
Research

Partners
International Distributors
Licenses & Accreditations
Payer

News & Events
Careers
IP

Connect with Us

Facebook
LinkedIn
X

©2026 Caris Life Sciences. All Rights Reserved.

Privacy & Website Policies

Terms & Conditions

Annual Notice to Physicians